-$1.42 (-0.97%)
| Source | Headline |
|---|---|
|
Impinj to Announce Second-Quarter 2026 Financial Results
SEATTLE--(BUSINESS WIRE)--Impinj to Announce Second-Quarter 2026 Financial Results. businesswire.com - 2026-07-06 16:15:00 |
|
Director Sells 33,000 Impinj Shares Worth $4.6 Million
33,412 shares were sold indirectly on June 4, 2026, with an estimated transaction value of ~$4.57 million based on the reported price of $136.84 per share. This sale represented 3.63% of Sylebra Capital LLC's indirect holdings in Impinj, reducing total indirect ownership from 921,467 to 888,055 shares. fool.com - 2026-06-30 06:44:01 |
|
Director Sells 45,000 Impinj Shares Worth $6.4 Million
45,037 shares were indirectly sold for a total transaction value of ~$6.4 million, based on a weighted average price of $141.87 per share during June 2–3, 2026. The sale represented 4.66% of Sylebra Capital LLC's indirect holdings, reducing indirect ownership from 967,000 to 921,467 shares; direct holdings remained at zero. fool.com - 2026-06-27 09:36:01 |
|
Intel vs. Impinj: Which Technology Stock Is a Better Buy in 2026?
Intel is aggressively expanding its foundry business and AI accelerator offerings to diversify beyond traditional PC and data center chips. Impinj maintains a specialized lead in RAIN RFID technology, though its revenue remains highly concentrated among a small number of partners. fool.com - 2026-06-18 06:30:01 |
|
Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
Insider sales are hitting two massive stocks in industrials and retail, as well as a small-cap chip stock. Across these names, insiders are sending bearish signals, but their severity differs meaningfully. marketbeat.com - 2026-06-17 12:55:56 |
|
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myel
New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combi gurufocus.com - 2026-06-13 07:00:00 |
|
Large Impinj Investor Trims Position by $11.3 Million
Impinj connects physical items to the digital world with advanced RFID solutions; a key insider recently reduced their indirect holdings. fool.com - 2026-06-05 16:11:39 |
|
Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
[url="]Imagion Biosystems, Ltd. (ASX: IBX)[/url] has announced that the US Food and Drug Administration (FDA) completed its review of the company's investigati gurufocus.com - 2026-06-02 12:00:00 |
|
Impinj (PI) Just Reclaimed the 200-Day Moving Average
After reaching an important support level, Impinj (PI) could be a good stock pick from a technical perspective. PI surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend. zacks.com - 2026-05-27 10:30:38 |
|
Impinj to Participate in Evercore Global TMT Conference
SEATTLE--(BUSINESS WIRE)--Impinj to Participate in Evercore Global TMT Conference. businesswire.com - 2026-05-26 16:15:00 |
|
Impinj (PI) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, Impinj (PI) is looking like an interesting pick, as it just reached a key level of support. PI recently overtook the 20-day moving average, and this suggests a short-term bullish trend. zacks.com - 2026-05-25 10:36:07 |
|
Is Impinj Inc (PI) Overvalued After 6.8% Rally? GF Value Says Overvalued
On May 22, 2026, Impinj Inc (PI) shares rose 6.8%, closing at $149.76. This positive movement comes amid a 52-week range that has seen a high of $247.06 and a l gurufocus.com - 2026-05-22 18:50:00 |
|
Impinj Inc (PI) Stock Down 4.7% but Still Overvalued -- GF Score: 73/100
On May 19, 2026, Impinj Inc (PI) shares fell 4.7% today, bringing the current price to $132.74. The stock has experienced a 52-week range from a low of $87.36 t gurufocus.com - 2026-05-19 19:39:00 |
|
This Beaten-Down Chip Stock Just Did Something It Hasn't Done in a Year. Time to Buy?
The catalyst lifted the chip stock to a 27% gain in the last two weeks. fool.com - 2026-05-12 01:00:00 |
|
How Impinj Stock Jumped 20.5% Today
Impinj posted falling profits but still beat expectations. Here's why investors celebrated the report. fool.com - 2026-04-30 17:54:11 |
|
This Chip Maker's Stock Is Soaring After Earnings. Analysts See 20% More Upside.
Chip maker Impinj is surging after beating earnings estimates and isuing better-than-expected second-quarter guidance. barrons.com - 2026-04-30 11:10:00 |
|
Impinj, Inc. (PI) Q1 2026 Earnings Call Transcript
Impinj, Inc. (PI) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-04-29 19:51:32 |
|
Impinj (PI) Tops Q1 Earnings and Revenue Estimates
Impinj (PI) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.21 per share a year ago. zacks.com - 2026-04-29 19:41:25 |
|
Impinj Reports First Quarter 2026 Financial Results
SEATTLE--(BUSINESS WIRE)--Impinj Reports First Quarter 2026 Financial Results. businesswire.com - 2026-04-29 16:15:00 |